RETRACTED ARTICLE: Stem cell membrane–camouflaged bioinspired nanoparticles for targeted photodynamic therapy of lung cancer
This record is marked as retracted by the source. Review the publisher’s notice before using its findings.
Source abstract
Abstract
Photodynamic therapy (PDT) with photosensitizers has been considered an effective strategy for treating tumors by generating reactive oxygen species (ROS) to induce tumor cells apoptosis or necrosis. However, the poor water solubility, rapid blood clearance, and lack of effective targeting of the photosensitizer are still a serious challenge for its satisfactory anti-cancer efficacy. Herein, we fabricated a stem cell membrane–camouflaged gelatin nanogels (Ng), which integrating the drug loading capacity of Ng and targeting ability of stem cell membrane, endowed with many unique advantages for targeted drug delivery. This bioinspired drug delivery system composed of hydrophobic photosensitizer, chlorin e6 (Ce6)-loaded gelatin nanogels (Ng) (Ng/Ce6), as the inner cores and coated stem cell membrane vesicles (SCV) as the outer shells, noted as Ng/Ce6@SCV. The averaged hydrodynamic diameter of Ng/Ce6@SCV was 202.7 ± 11.7 nm (polydispersity index (PDI) = 0.113). Ng/Ce6@SCV could efficiently promote the cellular internalization of Ce6, and generate enough ROS in the tumor cells after near infrared (NIR) laser irradiation, which could efficiently suppress the growth of A549 tumor cells in vitro. After administration, Ng/Ce6@SCV exhibited targeting accumulation and long-term retention at tumor tissues, which was related to the immune escape and tumor targeting ability of the stem cell membrane. The in vivo anti-tumor activity results also demonstrated the enhanced anti-tumor effect of Ng/Ce6@SCV after NIR irradiation by significantly suppressed the primary tumor growth with minimal side effects. All the results indicated this polyphosphoester-based bioinspired nanodrug delivery system could be a suitable strategy for precise and effective PDT of cancers.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (29)
Show source-provided references
1. Akinc A, Zumbuehl A, Goldberg M, Leshchiner ES, Busini V, Hossain N, Bacallado SA, Nguyen DN, Fuller J, Alvarez R (2008) A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol 26(5):561–56910.1038/nbt1402 ↗
2. Aryal S, Hu C-MJ, Fang RH, Dehaini D, Carpenter C, Zhang D-E, Zhang L (2013) Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release. Nanomedicine 8(8):1271–128010.2217/nnm.12.153 ↗
3. Castano AP, Demidova TN, Hamblin MR (2004) Mechanisms in photodynamic therapy: part one—photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther 1(4):279–29310.1016/S1572-1000(05)00007-4 ↗
4. Conti M, Tazzari V, Baccini C, Pertici G, Serino LP, De Giorgi U (2006) Anticancer drug delivery with nanoparticles. In Vivo 20(6A):697–701
5. Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5(3):161–17110.1038/nrc1566 ↗
6. Gao C, Lin Z, Wu Z, Lin X, He Q (2016a) Stem-cell-membrane camouflaging on near-infrared photoactivated upconversion nanoarchitectures for in vivo remote-controlled photodynamic therapy. ACS Appl Mater Interfaces 8(50):34252–3426010.1021/acsami.6b12865 ↗
7. Gao C, Lin Z, Jurado-Sánchez B, Lin X, Wu Z, He Q (2016b) Stem cell membrane-coated nanogels for highly efficient in vivo tumor targeted drug delivery. Small 12(30):4056–406210.1002/smll.201600624 ↗
8. Hare JI, Lammers T, Ashford MB, Puri S, Storm G, Barry ST (2017) Challenges and strategies in anti-cancer nanomedicine development: an industry perspective. Adv Drug Deliv Rev 108:25–3810.1016/j.addr.2016.04.025 ↗
9. Li L-L, Xu J-H, Qi G-B, Zhao X, Yu F, Wang H (2014) Core–shell supramolecular gelatin nanoparticles for adaptive and “on-demand” antibiotic delivery. ACS Nano 8(5):4975–498310.1021/nn501040h ↗
10. Li Y, Wu Q, Kang M, Song N, Wang D, Tang BZ (2020) Boosting the photodynamic therapy efficiency by using stimuli-responsive and AIE-featured nanoparticles. Biomaterials 232:11974910.1016/j.biomaterials.2019.119749 ↗
11. Liu Y, Meng X, Bu W (2019) Upconversion-based photodynamic cancer therapy. Coord Chem Rev 379:82–9810.1016/j.ccr.2017.09.006 ↗
12. Lu Z-R, Kopečková P, Kopeček J (1999) Polymerizable Fab′ antibody fragments for targeting of anticancer drugs. Nat Biotechnol 17(11):1101–110410.1038/15085 ↗
13. Lu J, Liong M, Zink JI, Tamanoi F (2007) Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 3(8):1341–134610.1002/smll.200700005 ↗
14. Luk BT, Fang RH, Hu C-MJ, Copp JA, Thamphiwatana S, Dehaini D, Gao W, Zhang K, Li S, Zhang L (2016) Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors. Theranostics 6(7):1004–101110.7150/thno.14471 ↗
15. Maeda H (2015) Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv Drug Deliv Rev 91:3–610.1016/j.addr.2015.01.002 ↗
16. Mansoori B, Mohammadi A, Doustvandi MA, Mohammadnejad F, Kamari F, Gjerstorff MF, Baradaran B, Hamblin MR (2019) Photodynamic therapy for cancer: role of natural products. Photodiagn Photodyn Ther 26:395–40410.1016/j.pdpdt.2019.04.033 ↗
17. Mima Y, Hashimoto Y, Shimizu T, Kiwada H, Ishida T (2015) Anti-PEG IgM is a major contributor to the accelerated blood clearance of polyethylene glycol-conjugated protein. Mol Pharm 12(7):2429–243510.1021/acs.molpharmaceut.5b00144 ↗
18. Oleinick NL, Morris RL, Belichenko I (2002) The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci 1(1):1–2110.1039/b108586g ↗
19. Parodi A, Quattrocchi N, van de Ven AL, Chiappini C, Evangelopoulos M, Martinez JO, Brown BS, Khaled SZ, Yazdi IK, Enzo MV (2013) Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol 8(1):61–6810.1038/nnano.2012.212 ↗
20. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2(12):751–76010.1038/nnano.2007.387 ↗
21. Singh S (2010) Nanomedicine–nanoscale drugs and delivery systems. J Nanosci Nanotechnol 10(12):7906–791810.1166/jnn.2010.3617 ↗
22. Tian W, Lu J, Jiao D (2019) Stem cell membrane vesicle–coated nanoparticles for efficient tumor-targeted therapy of orthotopic breast cancer. Polym Adv Technol 30(4):1051–106010.1002/pat.4538 ↗
23. Torchilin V (2011) Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63(3):131–13510.1016/j.addr.2010.03.011 ↗
24. Xu X, Ho W, Zhang X, Bertrand N, Farokhzad O (2015) Cancer nanomedicine: from targeted delivery to combination therapy. Trends Mol Med 21(4):223–23210.1016/j.molmed.2015.01.001 ↗
25. Xu L, Wu S, Zhou X (2018) Bioinspired nanocarriers for an effective chemotherapy of hepatocellular carcinoma. J Biomater Appl 33(1):72–8110.1177/0885328218772721 ↗
26. Xu L, Su T, Xu X, Zhu L, Shi L (2019a) Platelets membrane camouflaged irinotecan-loaded gelatin nanogels for in vivo colorectal carcinoma therapy. J Drug Deliv Sci Technol 53:10119010.1016/j.jddst.2019.101190 ↗
27. Xu L, Wu S, Wang J (2019b) Cancer cell membrane–coated nanocarriers for homologous target inhibiting the growth of hepatocellular carcinoma. J Bioact Compat Polym 34(1):58–7110.1177/0883911518819107 ↗
28. Xuan M, Shao J, Dai L, He Q, Li J (2015) Macrophage cell membrane camouflaged mesoporous silica nanocapsules for in vivo cancer therapy. Adv Healthc Mater 4(11):1645–165210.1002/adhm.201500129 ↗
29. Zhou Z, Song J, Nie L, Chen X (2016) Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. Chem Soc Rev 45(23):6597–662610.1039/C6CS00271D ↗